The medication is typically initiated at a lower dose and gradually titrated upward to minimize gastrointestinal side effects and optimize therapeutic benefit
Weight regain typically occurs over months, with substantial regain often seen within one year of discontinuation
Diabetes Obes Metab 23(2):508519 Shubrook JH, Radin M, Ali SN, Chubb B, DiPietrantonio K, Collings H, Wyn R, Smith M (2022) Preference for type 2 diabetes therapies in the United States: a discrete choice experiment
Unlike Semaglutide weight loss treatments (such as Ozempic and Wegovy), which activate only the GLP-1 receptor, Tirzepatide is a dual-action therapy that targets both GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors
Procurement-Friendly Options: Private Label Premium GLP-1 Capsules ( VIETNAM KANG SUYUAN INTERNATIONAL PHARMACEUTICAL CO.,LTD ) offers the lowest barrier to entry with an MOQ of 50 pieces , ideal for small-scale testing
Responsible use begins with ensuring eligibility